Drilldown: Medicines - Pharmacopedia

Nav

Choose a table:

Medicines (732)

Medicines > classes

: Cathinone

or Classic Psychedelic

or D2/D3/5HT1A partial agonist

Use the filters below to narrow your results.

None (83) · Delysid (historical, Sandoz, withdrawn 1965) (1) · Vraylar (1)

5-HT2A agonist (26) · Potent 5-HT2A agonist (5) · LSD analogue; 5-HT2A agonist (4) · Monoamine releasing agent (4) · Prodrug of LSD; 5-HT2A agonist (4) · Serotonin/norepinephrine/dopamine releasing agent (3) · Cathinone analogue; monoamine reuptake inhibitor (2) · Contains LSA (2) · Contains mescaline (2)

Other values:

None (84) · Schizophrenia (FDA-approved 2015). Acute manic or mixed episodes of bipolar I disorder. Bipolar I depression (FDA-approved 2019). Adjunctive treatment of major depressive disorder (FDA-approved Dec 2022). (1)

None (84) · Schizophrenia: 1.5 mg PO daily, increase to 1.5-6 mg as tolerated. Bipolar mania: 1.5 mg, may increase to 3-6 mg. Bipolar depression: 1.5 mg daily for 14 days, then 3 mg. MDD adjunct: 1.5 mg, may increase to 3 mg. (1)

None (84) · 1.5 mg, 3 mg, 4.5 mg, 6 mg capsules (1)

None (84) · 6 mg/d (psychosis/mania); 3 mg/d (depression adjunct) (1)

None (83) · Oral (2)

None (83) · 30–60 minutes (1) · Weeks for psychosis/mood efficacy (1)

None (83) · 8–12 hours (1) · Daily dosing; active metabolites with very long half-lives (up to 1-3 weeks) (1)

None (83) · 3–5 hours (1) · Cariprazine ~2-4 d; major active metabolites desmethyl-cariprazine (DCAR) ~1-3 weeks → 'oral depot' effect with delayed steady-state and reduced effect of missed doses (1)

None (83) · 70–90% (oral) (1) · Adequate oral bioavailability (1)

None (83) · Limited data (1) · Not established (1)

None (83) · Rx (1) · Schedule I (United States) (1)

Showing below up to 85 results in range #1 to #85.

1

2

3

3-MMC

4

5

A

B

C

D

E

H

Hawaiian Baby Woodrose

Hexedrone

L

M

N

P

S

San Pedro cactus

T

TMA-2

Y

Yopo

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"